Estimated prevalence of SARS-CoV-2 RNA reactive donations 1.16/100,000; no infectivity seen in inoculated permissive cell cultures
Testing for STIs in the U.S. Dropped During Early Pandemic
Low point in testing for chlamydia and gonorrhea seen in early April 2020, raising the possibility of many missed cases